Stanley W. Hulet

919 total citations
23 papers, 722 citations indexed

About

Stanley W. Hulet is a scholar working on Plant Science, Health, Toxicology and Mutagenesis and Insect Science. According to data from OpenAlex, Stanley W. Hulet has authored 23 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Plant Science, 12 papers in Health, Toxicology and Mutagenesis and 9 papers in Insect Science. Recurrent topics in Stanley W. Hulet's work include Pesticide Exposure and Toxicity (14 papers), Environmental Toxicology and Ecotoxicology (11 papers) and Insect and Pesticide Research (9 papers). Stanley W. Hulet is often cited by papers focused on Pesticide Exposure and Toxicity (14 papers), Environmental Toxicology and Ecotoxicology (11 papers) and Insect and Pesticide Research (9 papers). Stanley W. Hulet collaborates with scholars based in United States and Italy. Stanley W. Hulet's co-authors include James R. Connor, S K Powers, Waldemar Debinski, Denise M. Gibo, G. Yancey Gillespie, Robert J. Mioduszewski, Edward M. Jakubowski, Simone O. Heyliger, Paul Dabisch and Ellen J. Hess and has published in prestigious journals such as Journal of Neurochemistry, Biochemical Pharmacology and Journal of the Neurological Sciences.

In The Last Decade

Stanley W. Hulet

23 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley W. Hulet United States 13 198 188 139 129 112 23 722
Biao Shi United States 15 325 1.6× 179 1.0× 43 0.3× 39 0.3× 51 0.5× 27 692
Casilda V. Mura United States 19 513 2.6× 47 0.3× 145 1.0× 175 1.4× 81 0.7× 35 1.1k
Jinhyuk Bhin South Korea 17 605 3.1× 52 0.3× 119 0.9× 44 0.3× 117 1.0× 24 1.0k
Duane D. Winkler United States 19 827 4.2× 77 0.4× 36 0.3× 21 0.2× 90 0.8× 27 1.4k
Sanjeeva J. Wijeyesakere United States 11 186 0.9× 79 0.4× 158 1.1× 33 0.3× 35 0.3× 23 532
Servet Özcan Türkiye 16 406 2.1× 105 0.6× 72 0.5× 14 0.1× 107 1.0× 58 944
Anders Peterson Sweden 12 162 0.8× 23 0.1× 48 0.3× 81 0.6× 63 0.6× 24 514
Yingxin Zhuang United States 13 347 1.8× 26 0.1× 294 2.1× 31 0.2× 27 0.2× 19 991
Hana Im South Korea 15 345 1.7× 36 0.2× 24 0.2× 74 0.6× 47 0.4× 63 716
Xingxing Gu China 17 582 2.9× 220 1.2× 108 0.8× 22 0.2× 110 1.0× 48 1.0k

Countries citing papers authored by Stanley W. Hulet

Since Specialization
Citations

This map shows the geographic impact of Stanley W. Hulet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley W. Hulet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley W. Hulet more than expected).

Fields of papers citing papers by Stanley W. Hulet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley W. Hulet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley W. Hulet. The network helps show where Stanley W. Hulet may publish in the future.

Co-authorship network of co-authors of Stanley W. Hulet

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley W. Hulet. A scholar is included among the top collaborators of Stanley W. Hulet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley W. Hulet. Stanley W. Hulet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saxena, Ashima, Nicholas B. Hastings, Wei Sun, et al.. (2015). Prophylaxis with human serum butyrylcholinesterase protects Göttingen minipigs exposed to a lethal high-dose of sarin vapor. Chemico-Biological Interactions. 238. 161–169. 23 indexed citations
2.
Hulet, Stanley W., et al.. (2014). Comparison of sarin and cyclosarin toxicity by subcutaneous, intravenous and inhalation exposure in Gottingen minipigs. Inhalation Toxicology. 26(3). 175–184. 8 indexed citations
3.
Saxena, Ashima, Wei Sun, Paul Dabisch, et al.. (2011). Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Göttingen minipigs exposed to sarin vapor. Biochemical Pharmacology. 82(12). 1984–1993. 37 indexed citations
4.
Saxena, Ashima, Wei Sun, Nicholas B. Hastings, et al.. (2009). Human Serum Butyrylcholinesterase: A Bioscavenger for the Protection of Humans from Organophosphorus Exposure. 1 indexed citations
5.
Saxena, Ashima, Wei Sun, Paul Dabisch, et al.. (2008). Efficacy of human serum butyrylcholinesterase against sarin vapor. Chemico-Biological Interactions. 175(1-3). 267–272. 22 indexed citations
7.
McGuire, Jeffrey M., et al.. (2008). A Rapid and Sensitive Technique for Assessing Exposure VX via GC-MS-MS Analysis. Journal of Analytical Toxicology. 32(1). 63–67. 6 indexed citations
8.
McGuire, Jeffrey M., et al.. (2008). Gas Chromatography-Tandem Mass Spectrometry Analysis of Red Blood Cells from Göttingen Minipig® following Whole-Body Vapor Exposure to VX. Journal of Analytical Toxicology. 32(1). 57–52. 4 indexed citations
9.
Hulet, Stanley W., Edward M. Jakubowski, Bernard J. Benton, et al.. (2006). Estimating Lethal and Severe Toxic Effects in Minipigs Following 10, 60, and 180 Minutes of Whole-Body GB Vapor Exposure. Defense Technical Information Center (DTIC). 1 indexed citations
10.
Hulet, Stanley W., Ronald B. Crosier, Paul Dabisch, et al.. (2006). Comparison of Low-Level Sarin and Cyclosarin Vapor Exposure on Pupil Size of the Gottingen Minipig: Effects of Exposure Concentration and Duration. Inhalation Toxicology. 18(2). 143–153. 16 indexed citations
11.
Dabisch, Paul, David C. Burnett, Edward M. Jakubowski, et al.. (2005). Tolerance to the Miotic Effect of Sarin Vapor in Rats After Multiple Low-Level Exposures. Journal of Ocular Pharmacology and Therapeutics. 21(3). 182–195. 21 indexed citations
12.
Jakubowski, Edward M., James L. Edwards, Stanley W. Hulet, et al.. (2004). Quantitation of Fluoride Ion Released Sarin in Red Blood Cell Samples by Gas Chromatography-Chemical Ionization Mass Spectrometry Using Isotope Dilution and Large-Volume Injection. Journal of Analytical Toxicology. 28(5). 357–363. 38 indexed citations
15.
Hulet, Stanley W., John H. McDonough, & Tsung‐Ming Shih. (2002). The dose–response effects of repeated subacute sarin exposure on guinea pigs. Pharmacology Biochemistry and Behavior. 72(4). 835–845. 17 indexed citations
16.
Hulet, Stanley W., et al.. (2002). Ferritin Binding in the Developing Mouse Brain Follows a Pattern Similar to Myelination and Is Unaffected by the Jimpy Mutation. Developmental Neuroscience. 24(2-3). 208–213. 29 indexed citations
17.
Hulet, Stanley W., Simone O. Heyliger, S K Powers, & James R. Connor. (2000). Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. Journal of Neuroscience Research. 61(1). 52–60. 74 indexed citations
18.
Hulet, Stanley W., S K Powers, & James R. Connor. (1999). Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. Journal of the Neurological Sciences. 165(1). 48–55. 99 indexed citations
19.
Debinski, Waldemar, Denise M. Gibo, Stanley W. Hulet, James R. Connor, & G. Yancey Gillespie. (1999). Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas.. PubMed. 5(5). 985–90. 217 indexed citations
20.
Hulet, Stanley W., Ellen J. Hess, Waldemar Debinski, et al.. (1999). Characterization and Distribution of Ferritin Binding Sites in the Adult Mouse Brain. Journal of Neurochemistry. 72(2). 868–874. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026